Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Aveanna Healthcare Holdings Expects FY24 Revenue Of >$1.985B (Prior >$1.970B) Vs $1.979B Est

Author: Benzinga Newsdesk | August 08, 2024 06:41am

Revised Full Year 2024 Guidance

The following is our updated guidance reflecting our current expectations for revenue and Adjusted EBITDA for the full year 2024:

  • Revenue of greater than $1,985 million, updated from prior guidance of revenue of greater than $1,970 million
     

Consistent with prior practice, we are not providing guidance on net income at this time due to the volatility of certain required inputs that are not available without unreasonable efforts, including future fair value adjustments associated with our interest rate swaps and caps.

  • Adjusted EBITDA of greater than $158 million, updated from prior guidance of Adjusted EBITDA greater than $150 million

Posted In: AVAH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist